SEC Filing 8-K: Tobira Therapeutics, Inc.
July 25, 2016 5:24pm EDT
Source: SEC (Index ) via Sqoop
Form 8-K
- § Other Events;
- § Financial Statements and Exhibits;
Exhibits
99.1
Press Release titled “Tobira Therapeutics Announces Clinically and Statistically Significant Improvement in Liver Fibrosis from Phase 2b CENTAUR NASH Trial at One Year,” dated July 25, 2016.